Cardiology Specialist formulary list
For information on use of unlicensed medicines or medicines used 'off-label' - click here
The following medicines are approved for prescribing by or on the recommendation of a prescribing cardiology specialist:
| TAF SECTION | MEDICINE | SUMMARY OF RESTRICTED INDICATION | CATEGORY | PROTOCOL |
|
|
Metolazone (unlicensed) (2.5mg tablets- named patient) | Add on to loop diuretic in heart failure where there has been an inadequate response to bendroflumethiazide or where bendroflumethiazide has not been tolerated. |
 |
|
| Eplerenone tablets▼ | Post-MI in stable
patients with left ventricular ejection fraction < 40% and clinical signs of
heart failure. In addition to standard optimal therapy in NYHA class II (chronic) heart failure and left ventricular systolic dysfunction (LVEF < 30%) in patients with a recent (within 6 months) hospitalisation for a cardiovascular reason. |
|
Feb 2007 | |
| 2.3 | Disopyramide capsules, M/R tablets | |
||
| Flecainide tablets, M/R capsules | |
See SIGN 94 Cardiac arrhythmias in coronary heart disease | ||
| Fecainide injection |  |
|||
| Sotalol tablets | |
|||
| Propafenone tablets | |
|||
|
|
|
|
||
| Amiodarone injection, Sterile concentrate (for dilution and use as infusion) | |
|||
| Dronedarone tablets▼ |
Maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent AF in those who would otherwise have been considered for long term amiodarone therapy and in whom conventional first-line anti-arrhythmic medicines are ineffective, contraindicated or not tolerated. See local protocol for criteria for patient selection and further information. |
|
Dronedarone protocol (NHS Tayside Staffnet intranet link only) | |
|
|
Esmolol injection | |
CCU therapeutic schedule (NHS Tayside Staffnet intranet link only) | |
| Labetalol injection | Hypertensive emergencies | |
||
| Metoprolol injection | |
Tayside protocol: Treatment of Atrial Fibrillation (NHS Tayside Staffnet intranet link only) | ||
| Carvedilol tablets | Chronic heart failure due to LVSD (alternative to bisoprolol). | |
Tayside guideline: Treatment of Confirmed Heart Failure See SIGN 95 |
|
| 2.5 | Hydralazine tablets |
Hypertension if other agents not tolerated, contraindicated or ineffective. Heart failure – see Tayside guideline. |
|
Tayside guideline: Treatment of Confirmed Heart Failure See SIGN 95 |
| Methyldopa tablets | Hypertension where other agents are unsuitable under the direction of the Cardiovascular Risk clinic. | |
||
| Moxonidine tablets | Severe resistant hypertension under the direction of the Cardiovascular Risk clinic. | |
||
| Valsartan capsules or tablets | Post-MI patients with clinical evidence of heart failure and/or left ventricular dysfunction who are unable to tolerate ACE-inhibitors | |
See SIGN 93 | |
| 2.6 | GTN injection/infusion | |
Tayside GTN protocol for chest pain of suspected cardiac origin | |
| Ivabradine tablets▼ | Heart rate lowering for patients in New York Heart Association (NYHA) class II to IV with systolic dysfunction. Patients must be in sinus rhythm, have a heart rate ≥75 beats per minute despite optimal therapy (including a beta blocker) or when beta blockers are not tolerated or contraindicated. | |
||
| 2.7 | Dobutamine concentrate for intravenous infusion | |
CCU therapeutic schedule
|
|
| Dopamine concentrate for intravenous infusion | |
CCU therapeutic schedule
|
||
| Isoprenaline injection (unlicensed) | |
CCU therapeutic schedule
|
||
| 2.8 | Unfractionated heparin | |
NHS Tayside intravenous unfractionated heparin infusion protocol | |
| Fondaparinux injection (pre-filled syringe) | ACS in accordance with protocol. | |
Anticoagulation of patients with ACS
|
|
| Rivaroxaban▼tablets | Treatrment of confirmed DVT or PE. |
|
Ninewells Acute Medicine Unit (AMU) Management of suspected DVT(NHS Tayside Staffnet intranet link only) Perth Royal Infirmary (PRI) DVT Treatment Guideline(NHS Tayside Staffnet intranet link only) Suspected Acute DVT Management in Angus pathway (NHS Tayside Staffnet intranet link only) NHS Tayside Guidance for the Management of Suspected Acute Pulmonary Thromboembolism (PTE) (NHS Tayside Staffnet intranet link only) |
|
| Rivaroxaban▼tablets | Prevention of VTE in adult patients undergoing elective hip or knee replacement surgery. |
|
NHS Tayside Local Treatment Protocol (NHS Tayside Staffnet intranet link only) | |
| Warfarin tablets | Treatment of confirmed DVT or PE. |
|
Ninewells Acute Medicine Unit (AMU) Management of suspected DVT (NHS Tayside Staffnet intranet link only) Perth Royal Infirmary (PRI) DVT Treatment Guideline(NHS Tayside Staffnet intranet link only) Suspected Acute DVT Management in Angus pathway (NHS Tayside Staffnet intranet link only) NHS Tayside Guidance for the Management of Suspected Acute Pulmonary Thromboembolism (PTE) (NHS Tayside Staffnet intranet link only) |
|
| 2.9 | Prasugrel tablets | Prevention of atherothrombotic events in patients with ACS undergoing primary or delayed percutaneous coronary intervention in accordance with algorithm. | |
Angioplasty antiplatelet algorithm |
| Ticagrelor tablets | Prevention of atherothrombotic events in patients with ACS undergoing high risk PCI. Restricted to use in those patients unsuitable for treatment with prasugrel in accordance with algorithm. |
|
|
|
| Tirofiban intravenous infusion (Intravia® bag) | Prevention of early MI in accordance with protocol. | |
|
|
| Abciximab injection | Complex patients undergoing PCI in accordance with protocol. | |
||
| 2.10 | Tenecteplase injection | Pre-hospital or in-hospital thrombolysis in STEMI. | |
CCU therapeutic schedule
|
|
May be prescribed by Hospital Specialists only |
|
May be prescribed in General Practice under the direction of a Specialist |
